Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse

Background Maintenance therapy with 5-aminosalicylic acid (5-ASA) is a key strategy for preventing relapse in many patients with inflammatory bowel disease (IBD). Factors which disrupt 5–ASA delivery, such as non-adherence and 5-ASA switches, may destabilise symptom control. Aim To investigate the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, A, Hankins, M, Wiseman, G, Jones, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley 2013
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840705/
https://www.ncbi.nlm.nih.gov/pubmed/23834298
http://dx.doi.org/10.1111/apt.12396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840705/
https://www.ncbi.nlm.nih.gov/pubmed/23834298
http://dx.doi.org/10.1111/apt.12396

Ejemplares similares